Transforming growth factor-β1 gene polymorphism in renal transplant recipients

被引:23
作者
Chow, KM
Szeto, CC
Poon, P
Lau, WY
Lai, FMM
Li, PKT [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China
关键词
transforming growth factor-beta1 (TGF-beta 1); polymorphism; renal transplant; glomerular filtration rate;
D O I
10.1080/08860220500234915
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Cytokine transforming growth factor (TGF) is involved in regulation of tissue repair after injury. More recently, TGF-beta 1 codon 10 gene polymorphism has been shown to be associated with circulating TGF-beta levels. We tested whether TGF-beta 1 genotype polymorphism was predictive of renal allograft function decline. Patients and Methods. The study population consisted of 129 consecutive cadaveric or living related renal transplant recipients at our center between 1985 and 2001. The recipient TGF-beta 1 genotype polymorphism was determined from peripheral blood leucocytes DNA. The primary endpoint was rate of glomerular filtration rate decline between the first year and the third year of transplant. Results. Baseline glomerular filtration rate as estimated by MDRD study equation at 1 year measured 50 +/- 17 mL/min/ 1.73 m(2). At the end of the 3-year follow-up period, 52 patients (40%) experienced biopsy-confirmed acute rejections. Frequency and severity of allograft rejection did not differ with TGF-beta genotypes. However, the decline in glomerular filtration rate was significantly greater in Leu/Leu (TT) than Leu/Pro (CT) recipients, 6.3 +/- 16.9 mL/min/1.73 m(2) versus 0.1 +/- 10.2 mL/min/1.73 m(2), p = 0.04. Conclusion. Our results demonstrate that recipient TGF-beta 1 codon 10 Leu/Leu homozygosity is a potential risk factor of kidney allograft function decline.
引用
收藏
页码:671 / 675
页数:5
相关论文
共 21 条
[1]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[2]   TRANSFORMING GROWTH-FACTOR-BETA IN DISEASE - THE DARK SIDE OF TISSUE-REPAIR [J].
BORDER, WA ;
RUOSLAHTI, E .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :1-7
[3]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[4]   Renal mRNA levels as prognostic tools in kidney diseases [J].
Eikmans, M ;
Baelde, HJ ;
Hagen, EC ;
Paul, LC ;
Eilers, PHC ;
De Heer, E ;
Bruijn, JA .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (04) :899-907
[5]   RNA expression profiling as prognostic tool in renal patients: Toward nephrogenomics [J].
Eikmans, M ;
Baelde, HJ ;
De Heer, E ;
Bruijn, JA .
KIDNEY INTERNATIONAL, 2002, 62 (04) :1125-1135
[6]   High transforming growth factor-β and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection [J].
Eikmans, M ;
Sijpkens, YWJ ;
Baelde, HJ ;
De Heer, E ;
Paul, LC ;
Bruijn, JA .
TRANSPLANTATION, 2002, 73 (04) :573-579
[7]   Role of codon 10 and codon 25 polymorphisms on TGF-β1 gene expression and protein synthesis in stable renal allograft recipients [J].
Guo, Z ;
Binswanger, U ;
Knoflach, A .
TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) :2904-2906
[8]   Donor genomics influence graft events: The effect of donor polymorphisms on acute rejection and chronic allograft nephropathy [J].
Hoffmann, S ;
Park, J ;
Jacobson, LM ;
Muehrer, RJ ;
Lorentzen, D ;
Kleiner, D ;
Becker, YT ;
Hullett, DA ;
Mannon, R ;
Kirk, AD ;
Becker, BN .
KIDNEY INTERNATIONAL, 2004, 66 (04) :1686-1693
[9]  
Kitamura M, 1998, EXP NEPHROL, V6, P1
[10]  
Lacha J, 2001, Ann Transplant, V6, P39